Inicio › Enfermedad de obstrucción pulmonar crónica › Tennessee
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Tennessee
16 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- M3 Wake Research, Inc. ( Site 4440), Chattanooga
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07874815A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
- Premier Research Center, Llc- Site Number : 8400146, Hendersonville
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Trials Center of Middle Tennessee, LLC, Franklin
- Premier Research Center, LLC, Hendersonville
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
- The University of Tennessee Graduate School of Medicine, Knoxville
ReclutandoFase 4
Edades de 40 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07133880Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Meharry Medical College- Site Number : 8400133, Nashville
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hendersonville
- Research Site, Knoxville
- Research Site, Lebanon
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Knoxville
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Franklin
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
- Research Site, Tullahoma
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Fort Sanders Regional Medical Center (StatCare), Knoxville
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Franklin
- Research Site, Johnson City
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Knoxville
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Methodist LeBonheur Healthcare, Memphis
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT05181826Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.